vision changes on tirzepatide Why Your GLP-1 Medications (And What It Means) | Dr. Dan Tirzepatide for Medical Weight Loss

The FDA has documented cases of adverse events associated with compounded semaglutide products

Excessive sugar intake can alter the binding of dopamine D1 and mu-opioid receptors in key brain areas like the nucleus accumbens, a central part of the reward pathway

Adults switching to dulaglutide had no change in body weight or HbA1c

Some people report three to five additional bathroom trips per day during this phase

Once it is determined that a tirzepatide medication is right for you, a plan will be personalized to best meet your needs

Intracranial pressure changes: Studies indicate GLP-1 agonists may reduce cerebrospinal fluid production, potentially altering intracranial pressure in ways that could either cause or, interestingly, sometimes relieve headaches